JP Morgan Chase’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.33M | Sell |
378,932
-33,329
| -8% | -$300K | ﹤0.01% | 3690 |
|
|
2025
Q4 | $3.69M | Sell |
412,261
-26,723
| -6% | -$253K | ﹤0.01% | 3595 |
|
|
2025
Q3 | $4.17M | Buy |
438,984
+410,823
| +1,459% | +$4.12M | ﹤0.01% | 3515 |
|
|
2025
Q2 | $248K | Sell |
28,161
-977
| -3% | -$7.93K | ﹤0.01% | 5137 |
|
|
2025
Q1 | $218K | Buy |
29,138
+1,648
| +6% | +$13.1K | ﹤0.01% | 5208 |
|
|
2024
Q4 | $229K | Buy |
27,490
+9,225
| +51% | +$78.7K | ﹤0.01% | 5420 |
|
|
2024
Q3 | $127K | Sell |
18,265
-400
| -2% | -$2.71K | ﹤0.01% | 5598 |
|
|
2024
Q2 | $91.5K | Buy |
18,665
+3,604
| +24% | +$17.1K | ﹤0.01% | 5560 |
|
|
2024
Q1 | $87.4K | Sell |
15,061
-11,833
| -44% | -$72.7K | ﹤0.01% | 5730 |
|
|
2023
Q4 | $176K | Buy |
26,894
+3,631
| +16% | +$17K | ﹤0.01% | 5459 |
|
|
2023
Q3 | $112K | Sell |
23,263
-4,411
| -16% | -$22K | ﹤0.01% | 5404 |
|
|
2023
Q2 | $141K | Buy |
27,674
+26,896
| +3,457% | +$145K | ﹤0.01% | 5285 |
|
|
2023
Q1 | $4K | Hold |
778
| – | – | ﹤0.01% | 6310 |
|
|
2022
Q4 | $4K | Sell |
778
-1,397
| -64% | -$7.09K | ﹤0.01% | 6220 |
|
|
2022
Q3 | $14K | Buy |
2,175
+613
| +39% | +$3.47K | ﹤0.01% | 5902 |
|
|
2022
Q2 | $7K | Sell |
1,562
-16,533
| -91% | -$75.4K | ﹤0.01% | 6107 |
|
|
2022
Q1 | $91K | Buy |
18,095
+3,990
| +28% | +$25.4K | ﹤0.01% | 5553 |
|
|
2021
Q4 | $123K | Sell |
14,105
-762
| -5% | -$6.8K | ﹤0.01% | 5592 |
|
|
2021
Q3 | $138K | Buy |
14,867
+3,895
| +35% | +$39.3K | ﹤0.01% | 5414 |
|
|
2021
Q2 | $141K | Buy |
+10,972
| New | +$118K | ﹤0.01% | 5410 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6428 |
|
|
2019
Q2 | – | Sell |
-134
| Closed | -$4K | – | 6059 |
|
|
2019
Q1 | $4K | Buy |
+134
| New | +$4.93K | ﹤0.01% | 5636 |
|
|
2018
Q3 | – | Sell |
-8,426
| Closed | -$876K | – | 5862 |
|
|
2018
Q2 | $876K | Buy |
8,426
+2,136
| +34% | +$209K | ﹤0.01% | 3896 |
|
|
2018
Q1 | $795K | Buy |
6,290
+6,251
| +16,028% | +$604K | ﹤0.01% | 3802 |
|
|
2017
Q4 | $3K | Sell |
39
-149
| -79% | -$8.99K | ﹤0.01% | 5355 |
|
|
2017
Q3 | $11K | Buy |
+188
| New | +$10K | ﹤0.01% | 4710 |
|
|
2017
Q2 | – | Sell |
-31
| Closed | -$2K | – | 5270 |
|
|
2017
Q1 | $2K | Sell |
31
-19
| -38% | -$1.15K | ﹤0.01% | 4964 |
|
|
2016
Q4 | $2K | Sell |
50
-55
| -52% | -$3.38K | ﹤0.01% | 4942 |
|
|
2016
Q3 | $8K | Buy |
+105
| New | +$7.47K | ﹤0.01% | 4327 |
|
|
2016
Q2 | – | Sell |
-1,323
| Closed | -$307K | – | 4996 |
|
|
2016
Q1 | $307K | Buy |
+1,323
| New | +$320K | ﹤0.01% | 3503 |
|
|
2015
Q3 | – | Sell |
-2,468
| Closed | -$726K | – | 4126 |
|
|
2015
Q2 | $726K | Buy |
+2,468
| New | +$538K | ﹤0.01% | 3430 |
|
Other funds holding ZVRA
WP
NCM
VCM
ACM
